The Innovative Medicines Initiative
14 Dec 2017
The Innovative Medicines Initiative
Lenalidomide with rituximab for mantle cell lymphoma
Combination chemotherapy for multiple myeloma
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in multiple myeloma
Results of the AML 12 trial
Genetically profiling entire populations, starting with Estonia
How does ancestry affect your health?
Neuroblastoma and cell communication networks
Personalised medicine differs from precision medicine
Connecting personalised medicine research in Canada with Europe
Cancer Core Europe
Roche joining forces to forward precision oncology